Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Transplantation. 2018 Mar;102(3):e115–e120. doi: 10.1097/TP.0000000000002008

Table 3.

Patients with de novo FSGS post transplant

Patient 1 Patient 2
Age at current transplant 64 52
Gender Female Male
Number of current transplant 1 1
Source of transplant Living related Living related
Pretransplant diagnosis Diabetic nephropathy Diabetic nephropathy
Pretransplant treatment with TPE or Rituximab TPE and Rituximab None
Time to FSGS 7 64
Peak proteinuria (g/g) 9.01 6.3
Treatment TPE and Rituximab TPE and Rituximab
Response to treatment No Yes
Most recent proteinuria (g/g) 6 0.25